Susquehanna International Group
AGIO icon

Susquehanna International Group’s Agios Pharmaceuticals AGIO Stock Holding History

Susquehanna International Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.95M Sell
116,900
-719,100
-86% -$20.4M ﹤0.01% 4690
2025
Q4 		$22.8M Buy
836,000
+568,700
+213% +$20M ﹤0.01% 2070
2025
Q3 		$10.7M Buy
267,300
+207,300
+346% +$7.8M ﹤0.01% 2951
2025
Q2 		$2M Sell
60,000
-14,300
-19% -$433K ﹤0.01% 5784
2025
Q1 		$2.18M Buy
74,300
+10,200
+16% +$338K ﹤0.01% 5331
2024
Q4 		$2.11M Buy
64,100
+5,500
+9% +$258K ﹤0.01% 5203
2024
Q3 		$2.6M Sell
58,600
-25,400
-30% -$1.15M ﹤0.01% 4800
2024
Q2 		$3.62M Buy
84,000
+2,900
+4% +$105K ﹤0.01% 3974
2024
Q1 		$2.37M Sell
81,100
-4,800
-6% -$129K ﹤0.01% 4964
2023
Q4 		$1.91M Buy
85,900
+19,900
+30% +$446K ﹤0.01% 5454
2023
Q3 		$1.63M Buy
66,000
+50,900
+337% +$1.35M ﹤0.01% 5557
2023
Q2 		$428K Buy
15,100
+1,800
+14% +$44.8K ﹤0.01% 8677
2023
Q1 		$306K Sell
13,300
-11,400
-46% -$303K ﹤0.01% 9681
2022
Q4 		$694K Sell
24,700
-13,500
-35% -$380K ﹤0.01% 7037
2022
Q3 		$1.08M Buy
38,200
+2,500
+7% +$67.1K ﹤0.01% 6442
2022
Q2 		$791K Sell
35,700
-29,400
-45% -$664K ﹤0.01% 7104
2022
Q1 		$1.9M Buy
+65,100
New +$1.99M ﹤0.01% 5600
2021
Q4 		– Sell
-92,200
Closed -$4.25M – 13033
2021
Q3 		$4.25M Buy
92,200
+16,500
+22% +$797K ﹤0.01% 4242
2021
Q2 		$4.17M Sell
75,700
-122,300
-62% -$6.84M ﹤0.01% 4362
2021
Q1 		$10.2M Buy
198,000
+77,000
+64% +$3.81M ﹤0.01% 2736
2020
Q4 		$5.24M Buy
121,000
+39,200
+48% +$1.55M ﹤0.01% 3350
2020
Q3 		$2.86M Buy
81,800
+73,300
+862% +$3.21M ﹤0.01% 3951
2020
Q2 		$455K Sell
8,500
-97,200
-92% -$4.5M ﹤0.01% 7549
2020
Q1 		$3.75M Sell
105,700
-1,900
-2% -$87.8K ﹤0.01% 2951
2019
Q4 		$5.14M Buy
107,600
+60,500
+128% +$2.29M ﹤0.01% 2933
2019
Q3 		$1.53M Sell
47,100
-66,800
-59% -$2.77M ﹤0.01% 4774
2019
Q2 		$5.68M Sell
113,900
-182,900
-62% -$9.78M ﹤0.01% 2548
2019
Q1 		$20M Buy
296,800
+186,300
+169% +$10.9M 0.01% 1185
2018
Q4 		$5.09M Sell
110,500
-40,600
-27% -$2.51M ﹤0.01% 2267
2018
Q3 		$11.7M Buy
151,100
+31,900
+27% +$2.57M ﹤0.01% 1780
2018
Q2 		$10M Buy
119,200
+12,500
+12% +$1.09M ﹤0.01% 1936
2018
Q1 		$8.73M Buy
106,700
+77,200
+262% +$5.97M ﹤0.01% 1918
2017
Q4 		$1.69M Sell
29,500
-36,800
-56% -$2.32M ﹤0.01% 4219
2017
Q3 		$4.43M Buy
66,300
+30,400
+85% +$1.83M ﹤0.01% 2656
2017
Q2 		$1.85M Sell
35,900
-47,200
-57% -$2.41M ﹤0.01% 4046
2017
Q1 		$4.85M Sell
83,100
-65,500
-44% -$3.14M ﹤0.01% 2384
2016
Q4 		$6.2M Sell
148,600
-16,700
-10% -$876K ﹤0.01% 2104
2016
Q3 		$8.73M Buy
165,300
+87,600
+113% +$3.81M ﹤0.01% 1629
2016
Q2 		$3.25M Buy
77,700
+9,900
+15% +$489K ﹤0.01% 2800
2016
Q1 		$2.75M Buy
67,800
+17,600
+35% +$752K ﹤0.01% 3191
2015
Q4 		$3.26M Sell
50,200
-57,000
-53% -$3.74M ﹤0.01% 3136
2015
Q3 		$7.57M Sell
107,200
-51,500
-32% -$5.03M ﹤0.01% 2146
2015
Q2 		$17.6M Buy
158,700
+49,400
+45% +$5.32M 0.01% 1421
2015
Q1 		$10.3M Buy
109,300
+2,000
+2% +$224K ﹤0.01% 1851
2014
Q4 		$12M Buy
107,300
+36,800
+52% +$3.29M ﹤0.01% 1828
2014
Q3 		$4.33M Buy
70,500
+59,700
+553% +$2.57M ﹤0.01% 3235
2014
Q2 		$495K Buy
+10,800
New +$440K ﹤0.01% 7497

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Susquehanna International Group's AGIO Position: Q1 2026 in Review

Susquehanna International Group increased its Agios Pharmaceuticals (AGIO) stake by 18% in Q1 2026, buying an estimated $5.74M and bringing the position to 1,344,953 shares worth $45.5M. The position accounts for 0.01% of the portfolio, ranked #1367.

Susquehanna International Group first reported a position in AGIO in Q2 2014 and has held it in 42 quarters since. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Susquehanna International Group held 1,344,953 shares of Agios Pharmaceuticals worth $45.5M as of Q1 2026.
  • Susquehanna International Group bought 202,521 Agios Pharmaceuticals shares in Q1 2026, an estimated $5.74M.
  • Agios Pharmaceuticals made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1367 holding.
  • Susquehanna International Group first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 42 quarters since.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.